Article may be outdated

This article is 53 days old. Some details may have changed since publication.

Ars Technica·4 min read·medium

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Beth Mole
RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access
AI Summary

HHS Secretary Robert F. Kennedy Jr. has appointed several individuals with financial ties to wellness clinics to an FDA advisory panel reviewing injectable peptide drugs. FDA scientists continue to warn that these substances lack sufficient evidence of safety and efficacy.

Why it matters

This move highlights a significant conflict between political appointees and career scientists regarding the regulation of unproven medical treatments.

Dive DeeperCreate a free account to unlock

More meddling RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access Peptide drugs are popular, but FDA scientists warn they’re untested, may be harmful.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
politicshealthscience
Political Bias
Lean Left
LeftLean LCenterLean RRight
Confidence: 85%

The framing uses loaded language like 'meddling,' 'peddlers,' and 'dubious' to characterize the actions of the HHS Secretary.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in